Todd Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $669K | Hold |
27,801
| – | – | 0.01% | 158 |
|
|
2026
Q1 | $781K | Buy |
+27,801
| New | +$740K | 0.02% | 152 |
|
|
2025
Q4 | – | Sell |
-27,653
| Closed | -$705K | – | 186 |
|
|
2025
Q3 | $705K | Hold |
27,653
| – | – | 0.01% | 152 |
|
|
2025
Q2 | $670K | Hold |
27,653
| – | – | 0.01% | 148 |
|
|
2025
Q1 | $701K | Buy |
27,653
+4,022
| +17% | +$105K | 0.02% | 148 |
|
|
2024
Q4 | $627K | Sell |
23,631
-4,022
| -15% | -$109K | 0.02% | 146 |
|
|
2024
Q3 | $800K | Hold |
27,653
| – | – | 0.02% | 149 |
|
|
2024
Q2 | $774K | Buy |
27,653
+129
| +0.5% | +$3.55K | 0.02% | 180 |
|
|
2024
Q1 | $764K | Buy |
27,524
+19,800
| +256% | +$549K | 0.02% | 186 |
|
|
2023
Q4 | $222K | Sell |
7,724
-17,268
| -69% | -$522K | ﹤0.01% | 209 |
|
|
2023
Q3 | $829K | Hold |
24,992
| – | – | 0.02% | 177 |
|
|
2023
Q2 | $917K | Sell |
24,992
-5,999
| -19% | -$233K | 0.02% | 179 |
|
|
2023
Q1 | $1.26M | Buy |
30,991
+3,280
| +12% | +$142K | 0.03% | 168 |
|
|
2022
Q4 | $1.42M | Sell |
27,711
-1,366
| -5% | -$65.5K | 0.03% | 170 |
|
|
2022
Q3 | $1.27M | Buy |
29,077
+210
| +0.7% | +$10.2K | 0.04% | 167 |
|
|
2022
Q2 | $1.51M | Sell |
28,867
-2,360
| -8% | -$120K | 0.04% | 172 |
|
|
2022
Q1 | $1.62M | Buy |
31,227
+398
| +1% | +$20.7K | 0.04% | 173 |
|
|
2021
Q4 | $1.82M | Buy |
30,829
+3,526
| +13% | +$175K | 0.04% | 169 |
|
|
2021
Q3 | $1.17M | Sell |
27,303
-9,343
| -25% | -$414K | 0.03% | 177 |
|
|
2021
Q2 | $1.44M | Sell |
36,646
-6,167
| -14% | -$240K | 0.03% | 175 |
|
|
2021
Q1 | $1.55M | Buy |
42,813
+10,005
| +30% | +$355K | 0.04% | 172 |
|
|
2020
Q4 | $1.21M | Sell |
32,808
-2,039
| -6% | -$74.8K | 0.03% | 170 |
|
|
2020
Q3 | $1.21M | Buy |
34,847
+83
| +0.2% | +$2.91K | 0.04% | 167 |
|
|
2020
Q2 | $1.08M | Hold |
34,764
| – | – | 0.03% | 177 |
|
|
2020
Q1 | $1.08M | Buy |
+34,764
| New | +$1.18M | 0.04% | 168 |
|
|
2017
Q3 | – | Sell |
-544,392
| Closed | -$17.3M | – | 220 |
|
|
2017
Q2 | $17.3M | Sell |
544,392
-11,386
| -2% | -$359K | 0.49% | 85 |
|
|
2017
Q1 | $18M | Sell |
555,778
-29,406
| -5% | -$927K | 0.52% | 77 |
|
|
2016
Q4 | $18M | Sell |
585,184
-47,242
| -7% | -$1.44M | 0.54% | 71 |
|
|
2016
Q3 | $20.3M | Buy |
+632,426
| New | +$21.1M | 0.61% | 62 |
|
|
2016
Q2 | – | Sell |
-581,556
| Closed | -$16.4M | – | 231 |
|
|
2016
Q1 | $16.4M | Sell |
581,556
-11,159
| -2% | -$319K | 0.49% | 83 |
|
|
2015
Q4 | $18.2M | Sell |
592,715
-23,983
| -4% | -$754K | 0.55% | 59 |
|
|
2015
Q3 | $18.4M | Sell |
616,698
-17,218
| -3% | -$552K | 0.58% | 57 |
|
|
2015
Q2 | $20.2M | Sell |
633,916
-3,872
| -0.6% | -$126K | 0.55% | 58 |
|
|
2015
Q1 | $21.1M | Sell |
637,788
-2,626
| -0.4% | -$83.5K | 0.59% | 50 |
|
|
2014
Q4 | $18.9M | Sell |
640,414
-371,833
| -37% | -$10.7M | 0.53% | 60 |
|
|
2014
Q3 | $28.4M | Buy |
1,012,247
+7,362
| +0.7% | +$207K | 0.81% | 42 |
|
|
2014
Q2 | $28.3M | Sell |
1,004,885
-607,030
| -38% | -$17.3M | 0.8% | 44 |
|
|
2014
Q1 | $49.1M | Buy |
1,611,915
+36,814
| +2% | +$1.1M | 1.42% | 16 |
|
|
2013
Q4 | $45.8M | Buy |
1,575,101
+99,759
| +7% | +$2.9M | 1.33% | 25 |
|
|
2013
Q3 | $40.2M | Sell |
1,475,342
-25,150
| -2% | -$684K | 1.23% | 32 |
|
|
2013
Q2 | $39.9M | Buy |
+1,500,492
| New | +$41.5M | 1.3% | 26 |
|
Other funds holding PFE
Todd Asset Management's PFE Position: Q2 2026 in Review
Todd Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 27,801 shares worth $669K. The position accounts for 0.01% of the portfolio, ranked #158.
Todd Asset Management first reported a position in PFE in Q2 2013 and has held it in 41 quarters since. The position peaked at $49.1M in Q1 2014. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Todd Asset Management held 27,801 shares of Pfizer worth $669K as of Q2 2026.
- Todd Asset Management left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.01% of Todd Asset Management's portfolio in Q2 2026, its #158 holding.
- Todd Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 41 quarters since.
- Todd Asset Management's Pfizer position peaked at $49.1M in Q1 2014.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Todd Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.